These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1479217)

  • 1. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hereditary changes of apolipoproteins B and E].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
    Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of type III hyperlipoproteinemia.
    Guyton JR
    Am Heart J; 1999 Jul; 138(1 Pt 1):17-8. PubMed ID: 10385757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
    Ziemer A; Göring HD
    Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
    Murase T; Okubo M; Takeuchi I
    J Clin Lipidol; 2010; 4(2):99-104. PubMed ID: 21122636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
    Havel RJ
    Med Clin North Am; 1982 Mar; 66(2):441-54. PubMed ID: 7040846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apolipoprotein E and apolipoprotein E phenotype].
    Matsunaga A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():114-6. PubMed ID: 15658277
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 13. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic image. A woman with orange hand lines].
    Bouwmans EM; Assouiki F
    Ned Tijdschr Geneeskd; 2009; 153():B452. PubMed ID: 19857303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Stuyt PM; Mol MJ; Stalenhoef AF; Demacker PN; Van 't Laar A
    Am J Med; 1990 Jan; 88(1N):42N-45N. PubMed ID: 2368763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial apolipoprotein E deficiency.
    Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
    J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.
    Rawlings AV; Deegan T
    J Inherit Metab Dis; 1988; 11 Suppl 2():135-8. PubMed ID: 3141692
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features of type III hyperlipoproteinaemia.
    Stuyt PM; Van 't Laar A
    Neth J Med; 1983; 26(4):104-11. PubMed ID: 6855990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.